A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

Dominique Bremond-Gignac1 Ophthalmology Department, Centre St Victor, University Hospital of Amiens, Picardie Jules Verne University, Amiens, France;2 CNRS FR3636, Paris V University, FranceCorrespondence[email protected]

Riadh Messaoud3 Ophthalmology Department, Tahar Sfar University Hospital, Mahdia, Tunisia

Sihem Lazreg4 Dar El Beida, Blida, Algeria

Claude Speeg-Schatz5 Ophthalmology Department, University Hospital of Strasbourg, Strasbourg, France

Didier Renault6 Laboratoires THÉA, Clermont-Ferrand, France

Frédéric Chiambaretta7 Ophthalmology Department, University Hospital of Clermont-Ferrand, Gabriel Montpied Hospital, Clermont-Ferrand, France;8 EA 7281 R2D2, Auvergne University, Clermont-Ferrand, France

Pages 725-732 | Published online: 20 Apr 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

McDonnellPJHow do general practitioners manage eye disease in the community?Br J Ophthalmol198872107337363191073
PubMed Web of Science ®Google Scholar
McCormickMFlemingDCharltonJMorbidity Statistics from General Practice: Fourth National Survey 1991–1992LondonHMSO1995
Google Scholar
MahFBacterial conjunctivitis in pediatrics and primary carePediatr Clin North Am200653Suppl 171016898650
PubMed Web of Science ®Google Scholar
SyedNAChandlerJWBacterial conjunctivitisTabbaraKFHyndiukRAInfections of the Eye82nd edBoston, USALittle, Brown and Co19866984
Google Scholar
HovdingGAcute bacterial conjunctivitisActa Ophthalmol200886151717970823
PubMed Web of Science ®Google Scholar
GigliottiFWilliamsWTHaydenFGEtiology of acute conjunctivitis in childrenJ Pediatr19819845315366970802
PubMed Web of Science ®Google Scholar
GrossRDHoffmanROLindsayRNA comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in childrenClin Pediatr1997368435444
Web of Science ®Google Scholar
BertinoJSJrImpact of antibiotic resistance in the management of ocular infections: the role of current and future antibioticsClin Ophthalmol2009350752119789660
PubMedGoogle Scholar
GoldeKTGardinerMFBacterial conjunctivitis in children: a current review of pathogens and treatmentInt Ophthalmol Clin2011514859221897142
PubMedGoogle Scholar
SheikhAHurwitzBvan SchayckCPMcLeanSNurmatovUAntibiotics versus placebo for acute bacterial conjunctivitisCochrane Database Syst Rev20129CD00121122972049
PubMed Web of Science ®Google Scholar
Garnock-JonesKPAzithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitisDrugs201272336137322316352
PubMed Web of Science ®Google Scholar
Bremond-GignacDNezzarHBianchiPEEfficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitisBr J Ophthalmol201498673974524526744
PubMed Web of Science ®Google Scholar
MessmerEMBakterielle Konjunktivitis – Update zu Diagnose und Therapie. [Bacterial conjunctivitis – diagnosis and therapy update]Klin Monbl Augenheilkd20122295529533 German22592344
PubMed Web of Science ®Google Scholar
JacksonWBLowDEDattaniDWhitsittPFLeederRGMacDougallRTreatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs 0.3% tobramycin dropsCan J Ophthalmol200237422823712095096
PubMed Web of Science ®Google Scholar
MilazzoGPapaVCarstoceaBTopical netilmicin compared with tobramycin in the treatment of external ocular infectionInt J Clin Pharmacol Ther199937524324810363623
PubMed Web of Science ®Google Scholar
ProtzkoEBowmanLAbelsonMShapiroAAzaSite Clinical Study GroupPhase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitisInvest Ophthalmol Vis Sci20074883425342917652708
PubMed Web of Science ®Google Scholar
AbelsonMProtzkoEShapiroAGarces-SoldanaABowmanLA randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitisClin Ophthalmol20071217718219668507
PubMedGoogle Scholar
CagleGDAbshireRIQuantitative ocular microbiology: a method for the enumeration and identification of bacteria from the skin-lash margin and conjunctivaInvest Ophthalmol Vis Sci19812067517577239845
PubMed Web of Science ®Google Scholar
Gueylard ChenevierDLeLorierJA willingness-to-pay assessment of parents’ preference for shorter duration treatment of acute otitis media in childrenPharmacoeconomics200523121243125516336018
PubMed Web of Science ®Google Scholar
RosePWZieblandSHarndenAMayon-WhiteRMantDOxford Childhood Infection Study group (OXCIS)Why do general practitioners prescribe antibiotics for acute infective conjunctivitis in children? Qualitative interviews with GPs and a questionnaire survey of parents and teachersFam Pract200623222623216339771
PubMed Web of Science ®Google Scholar
SheikhAHurwitzBvan SchayckCPMcLeanSNurmatovUAntibiotics versus placebo for acute bacterial conjunctivitisCochrane Database Syst Rev20129CD00121122972049
PubMed Web of Science ®Google Scholar
KerntKMartinezMABertinDA clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitisEur J Ophthalmol200515554154916167284
PubMed Web of Science ®Google Scholar
RotchfordAPMurphyKMCompliance with timolol treatment in glaucomaEye (Lond)199812Pt 22342369683946
PubMed Web of Science ®Google Scholar
PatelSCSpaethGLCompliance in patients prescribed eyedrops for glaucomaOphthalmic Surg19952632332367651690
PubMedGoogle Scholar
KardasPPatient compliance with antibiotic treatment for respiratory tract infectionsJ Antimicrob Chemother200249689790312039881
PubMed Web of Science ®Google Scholar
TenoverFCMcGowanJEJrReasons for the emergence of antibiotic resistanceAm J Med Sci199631119168571988
PubMed Web of Science ®Google Scholar
KardasPBishaiWRCompliance in anti-infective medicineAdv Stud Med20066S652S658
Google Scholar
KassMNon-compliance to ocular therapyAnn Ophthalmol19781012441245
Google Scholar
LodeHBornerKKoeppePSchabergTAzithromycin – review of key chemical, pharmacokinetic and microbiological featuresJ Antimicrob Chemother199637Suppl C188818841
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date